Literature DB >> 20461330

Time-course and determinants of spasticity during the first six months following first-ever stroke.

Erik Lundström1, Anja Smits, Andreas Terént, Jörgen Borg.   

Abstract

OBJECTIVE: To explore the occurrence of, and risk factors for, spasticity until 6 months after first-ever stroke.
METHODS: Forty-nine patients were examined at day 2-10, at 1 month, and at 6 months. The modified Ashworth Scale was used to assess resistance to passive movements. A comprehensive clinical examination was performed to identify other positive signs of upper motor neurone syndrome, in accordance with a broader definition of spasticity, and to evaluate whether spasticity was disabling. Neurological impairments were determined by use of the National Institutes of Health Stroke Scale and global disability by use of the modified Rankin Scale.
RESULTS: Spasticity was present in 2 patients (4%) at day 2-10, in 13 patients (27%) at 1 month, and in 11 patients (23%) at 6 months. Severe paresis of the arm at day 2-10 was associated with a higher risk for spasticity at 1 month (odds ratio = 10, 95% confidence interval 2.1-48.4). Disabling spasticity was present in one patient at 1 month and in 6 patients (13%) at 6 months.
CONCLUSION: Spasticity according to the modified Ashworth Scale usually occurs within 1 month and disabling spasticity later in a subgroup. Severe paresis of the arm is a risk factor for spasticity.

Entities:  

Mesh:

Year:  2010        PMID: 20461330     DOI: 10.2340/16501977-0509

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  31 in total

1.  Botulinum toxin type A combined with neurodynamic mobilization for lower limb spasticity: a case report.

Authors:  Jorge H Villafañe
Journal:  J Chiropr Med       Date:  2013-03

2.  Efficacy of Short-Term Robot-Assisted Rehabilitation in Patients With Hand Paralysis After Stroke: A Randomized Clinical Trial.

Authors:  Jorge H Villafañe; Giovanni Taveggia; Silvia Galeri; Luciano Bissolotti; Chiara Mullè; Grace Imperio; Kristin Valdes; Alberto Borboni; Stefano Negrini
Journal:  Hand (N Y)       Date:  2017-02-16

3.  Spasticity.

Authors:  Raphael Rush; Dinesh Kumbhare
Journal:  CMAJ       Date:  2014-11-17       Impact factor: 8.262

4.  Botulinum toxin type A combined with neurodynamic mobilization for upper limb spasticity after stroke: a case report.

Authors:  Jorge H Villafañe; Guillermo B Silva; Alessandro Chiarotto; Orazio L F Ragusa
Journal:  J Chiropr Med       Date:  2012-09

5.  Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey.

Authors:  Giorgio Sandrini; A Baricich; C Cisari; Stefano Paolucci; Nicola Smania; A Picelli
Journal:  Funct Neurol       Date:  2018 Jan/Mar

6.  Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report.

Authors:  Jorge H Villafañe; Cesar Fernandez-de-Las-Peñas; Paolo Pillastrini
Journal:  J Chiropr Med       Date:  2012-12

7.  Non-pharmacological intervention for rehabilitation of post-stroke spasticity: A protocol for systematic review and network meta-analysis.

Authors:  Guanyu Hu; Hongshi Zhang; Yufeng Wang; Deyu Cong
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

8.  Gait improvement by low-dose botulinum toxin A injection treatment of the lower limbs in subacute stroke patients.

Authors:  Wu Tao; Dong Yan; Jian-Hua Li; Zhao-Hong Shi
Journal:  J Phys Ther Sci       Date:  2015-03-31

9.  Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study.

Authors:  Alessandro Picelli; Andrea Santamato; Michela Cosma; Alessio Baricich; Carmelo Chisari; Marzia Millevolte; Cristina Del Prete; Ilenia Mazzù; Paolo Girardi; Nicola Smania
Journal:  Toxins (Basel)       Date:  2021-05-24       Impact factor: 4.546

10.  Effects of brain-computer interface training on upper limb function recovery in stroke patients: A protocol for systematic review and meta-analysis.

Authors:  Xiali Xue; Huan Tu; Zhongyi Deng; Ling Zhou; Ning Li; Xiaokun Wang
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.